Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus propofol during ventricular tachycardia ablation
ACTRN12623000825651Phase 4Recruiting
- Sponsor
- Departments of Anaesthesia, Cardiology - Westmead Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevoflurane and propofol in ventricular tachycardia (VT) (2 arms), sponsored by Departments of Anaesthesia, Cardiology - Westmead Hospital. Primary endpoint: VT inducibility. Started Jun 2023; status: recruiting.
02
Drugs
sevofluranepropofol
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on ACTRN12623000825651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000825651.